NCT07291999Active, not recruiting
Tissue Characterization in STEMI Using Cardiac MRI: a Multicenter Registry
Tissue Characterization in ST-Segment Elevation Myocardial Infarction: A Multicenter Registry of Patients Evaluated With Cardiac Magnetic Resonance
Source: ClinicalTrials.gov · Last updated 18 Dec 2025
Brief summary (registry, in English)
This multicenter registry includes patients with a first ST-segment elevation myocardial infarction (STEMI) who underwent cardiac magnetic resonance (CMR) imaging during the acute phase and follow-up. The registry is designed to identify clinical and CMR-derived predictors of adverse ventricular remodeling and major adverse cardiac events (MACE). CMR provides accurate and reproducible assessment of infarct size, left ventricular function, microvascular obstruction, and tissue characteristics, enabling detailed prognostic modeling.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 500 (actual)
- First submitted
- 25 Nov 2025
- Start date
- 1 Jan 2025
- Primary completion date
- 30 Sept 2025
- Lead sponsor
- Fundación para la Investigación del Hospital Clínico de Valencia
- Diseases
- Coronary artery disease
- NCT number
- NCT07291999
What you commit to
- Study type: Observational
- Participants enrolled: 500
- From 1 Jan 2025 to the primary completion date, 30 Sept 2025
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Lab values
- Severe renal failure (GFR \< 30 ml/min)
Other
- STEMI \> 24 hours after symptom onset
- Contraindications to CMR (e.g., claustrophobia, hemodynamic instability, non-MR-compatible devices, vascular clips)
- Pregnancy or breastfeeding.
Who the study is looking for
- Age ≥ 18 years
- First STEMI evaluated within the first 24 hours of symptom onset
- At least one CMR performed during the acute phase
- Signed informed consent (for prospective patients) or previous consent (for retrospective inclusion).
Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hospital Clinic de Barcelona Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Hospital Vall d'Hebron de Barcelona Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Hospital Clínico de Valencia Coordinator of this site? Confirm its status | Valencia | Spain | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.